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Insights for improving malaria, family planning, and maternal and child health
outcomes in northwestern Nigeria through social and behavior change research

Routine childhood immunization
This brief provides rigorous evidence-based
insights to implementers and researchers of
social and behavior change (SBC) programs that
seek to improve community knowledge, attitudes, norms and behaviors for improved health
of women and their young children. The brief
focuses on key outcomes in routine childhood
immunization, including receipt of all basic vaccinations needed for a child to be considered fully
immunized by their first birthday according to the
Nigerian Ministry of Health (BCG, three doses of
oral polio vaccine, three doses of DPT vaccine and
one dose of measles vaccine), while also uncovering the barriers and facilitators to vaccine uptake.
It is one of a series that present findings from a
Breakthrough RESEARCH study that uniquely captures data on a wide range of psychosocial drivers
of behavioral outcomes in the areas of family
planning, malaria, and maternal, newborn and
child health, and nutrition (MNCH+N). The results
presented in this series will inform the improvement of women and children’s health in Nigeria
and help to achieve the objectives of the Nigerian
Reproductive Health Policy,1 as well as support
global efforts to achieve the United Nations Sustainable Development Goals.2

Breakthrough RESEARCH and
Breakthrough ACTION in Nigeria
Breakthrough RESEARCH and ACTION are USAID’s flagship
SBC programs. Breakthrough ACTION in Nigeria implements
SBC programming in eleven states and the Federal Capital

KEY POINTS
Very few children (6%) aged 12–23 months in
northwestern Nigeria were fully immunized by
their first birthday.
Spousal opposition, health system problems,
and vaccine concerns were the main barriers to
vaccinating children.
Spouses play a dominant role in vaccination
decisions, and SBC programs should involve
spouses to increase vaccine uptake. More research is needed to better understand reasons
for spousal opposition.
Women who said health providers influenced
their vaccination decisions were significantly
more likely to get their child vaccinated than
those who did not. SBC programs could focus
on provider behaviors around vaccine promotion, such as during health talks at ANC visits.
SBC programs should reinforce messages about
vaccine safety and efficacy, and help build
community trust in providers delivering immunization services.
Antenatal care visits may be an important
moment to improve community views of health
services quality, address women’s vaccine hesitancy, and expand the reach of health worker
influence for vaccinations.
Programs may need to take a whole system
approach, including SBC programs targeted at
multiple societal levels alongside health system
strengthening efforts.

Territory (FCT) by targeting key psychosocial
factors at multiple socio-ecological levels
(e.g. individual, community, society) in order
to improve health behaviors in the areas
of malaria, family planning and maternal,
newborn and child health plus nutrition
(MNCH+N). Breakthrough RESEARCH in Nigeria
conducts rigorous research to inform SBC
program implementation in three of these
program states (Kebbi, Sokoto and Zamfara).
Findings presented here are from a Breakthrough RESEARCH baseline study that will
be used to inform SBC program adaption and
scale-up in Nigeria.

TABLE 1 NIGERIA’S ROUTINE CHILD IMMUNIZATION SCHEDULE
AGE OF CHILD VACCINATION

DISEASE PROTECTION

At birth

Hepatitis B vaccine (HBV 1)

Hepatitis B

Oral polio vaccine (OPV 0)

Polio

BCG vaccine

Tuberculosis

OPV 1

Polio

Pentavalent 1

DPT, Hib and hepatitis B

Rotavirus vaccine 1

Rotavirus

PCV 1

Pneumonia and otitis media

OPV 2

Polio

Pentavalent 2

DPT, Hib and hepatitis B

Rotavirus vaccine 2

Rotavirus

PCV 2

Pneumonia and otitis media

OPV 3

Polio

Pentavalent 3

DPT, Hib and hepatitis B

PCV 3

Pneumonia and otitis media

6 months

Vitamin A

Vitamin A deficiency

9 months

Measles vaccine

Measles

Yellow fever vaccine

Yellow fever

Meningitis vaccine

Meningitis and septicemia

Vitamin A

Vitamin A deficiency

OPV booster

Polio

MMR

Measles, mumps, rubella

Chicken pox vaccine

Chicken pox

Typhoid vaccine

Typhoid

6 weeks

10 weeks

Setting the context
Routine childhood immunization is one of the
most cost-effective public health interventions
and has been estimated to avert approximately 2 to 3 million deaths per year.3 Yet, vaccination rates in northwestern Nigeria remain
extremely low. According to the Nigerian
Ministry of Health, a child is considered fully
immunized if he/she receives a BCG vaccine
against tuberculosis, three doses of DPT to
prevent diphtheria, pertussis, and tetanus,
at least three doses of polio vaccine and one
dose of measles vaccine (Table 1). In 2018,
only 20 percent of children 12–23 months
in northwestern Nigeria were considered
fully immunized by one year of age, or who
received all basic vaccinations before their
first birthday based on data collection among
children aged 12–23 months.4

14 weeks

12–24 months

15–18 months
24 months

Several studies indicate that low vaccination
Girls aged
rates in this region may be related to facility
13+ years
distance, concerns about vaccine safety and
perceived side effects, antenatal care attendance, lack of social support for immunization,
irregular vaccine supply at health facilities as well as wealth,
education, and employment.5–7 Other studies suggest that
polio immunization campaigns, which may occur several
times per year, distract from routine immunization service
delivery and may have led to persistent vaccine myths within
this region.8
Family decision-making processes are multifaceted and
influenced by the complex interaction of knowledge, beliefs,
social norms, and other psychosocial factors that are posited by theories as intermediate determinants of behavior
change.9,10 We adapted the World Health Organization’s
vaccine hesitancy metrics to the northwestern Nigerian
context in order to develop a set of ideational metrics for this
2

Human papilloma virus (HPV) Cervical cancer caused by
vaccine
HPV types 16 and 18
study.11,12 This research brief aims to describe different barriers to routine immunization uptake, quantify the importance
of ideational factors on vaccine behaviors, and measure
the extent to which SBC programs may effectively change
vaccination practices by targeting identified psychosocial
influences.

Study methods
Results are based on the behavioral sentinel surveillance
(BSS) baseline survey that was conducted between September and October 2019 in Breakthrough ACTION program
areas in Kebbi, Sokoto and Zamfara. Figure 1 summarizes the
study methods.
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FIGURE 1 BSS BASELINE SURVEY STUDY
METHODS
Study
Pregnant women and women with under-2s
population living within Breakthrough ACTION program

areas in Kebbi, Sokoto andd Zamfara states (not
representative at state level)

Study
design

MAP 1 VERY LOW RATES OF FULLY VACCINATED
CHILDREN 12–23 MONTHS ACROSS
LOCAL GOVERNMENT AREAS
Percentage of last-born children aged 12–23 months who
received all basic vaccinations by local government area.
Sokoto

Cross-sectional and cohort components

Zamfara
Kebbi

Sample
size

3,032 pregnant women
3,043 women with a child under 2 years

Sampling 108 wards across 3 states
method Census of pregnant women
Random selection of women with a child under 2
years
Data
analysis

Mixed-effects logistic regression models were
used to derive predicted probabilities for ANC4+
(four or more visits) and facility-based delivery,
controlling for pregnancy-related ideations and
sociodemographic characteristics, including
household wealth, age, education (woman and
spouse), and employment (woman and spouse).

Key results

Not a sampled area

<10%

10–24%

25–39%

≥40%

FIGURE 2 LOW RATES OF ROUTINE CHILDHOOD
IMMUNIZATIONS BY VACCINE TYPE
Percentage of last-born children aged 12–23 months who
received all basic vaccinations by the survey interview date
(BCG vaccine, 3 doses of oral polio vaccine, 1 dose of measles
vaccine, and 3 doses of DPT vaccine), by vaccine type

Very low routine childhood immunization rates

•

•

Very few children aged 12–23 months were fully immunized by their first birthday (6%). Slightly higher percentages of children 12–23 months received: BCG (27%), three
doses of oral polio (27%), one dose of measles (18%), and
three doses of DPT (10%).
Vaccination coverage inequities exist with <4% of children
12–23 months receiving all basic vaccinations in the lowest, second, and middle wealth quintiles compared to 9%
and 16% in the fourth and highest quintiles.

BCG vaccination

27%

Polio vaccination
(3 doses)

27%

Measles vaccination
(1 dose)

Low vaccine knowledge, common myths, spousal
opposition and health services problems

DPT vaccination
(3 doses)

Only 25% of respondents knew that a child should get
their first routine immunization at birth. Nearly half (46%)
said they did not know the timing of the first vaccination.

All basic vaccinations

•
•

18%

10%

6%

More than one-quarter (28%) of respondents believed
vaccines were either not effective or were unsure about
their effectiveness. More than half (54%) believed or were
unsure if vaccines contain chemicals that are dangerous to a child’s health. Nearly one-quarter cited vaccine
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•

concerns as reasons for not getting their child vaccinated
including fear of needles (11%), fear of side effects or
safety issues (10%), or lack of effectiveness (2%).
Among women who did not vaccinate their youngest
child, one-third (33%) cited spousal opposition as a reason
for not doing so. Over one-third cited an issue related to
health services quality including facility distance (14%),
closure (9%), cost (6%), no female provider (4%), disrespectful provider (1%), or poor-quality service (4%) (Table
2).

Programmatic implications
9 Reasons for not vaccinating children are complex
and multi-faceted including spousal opposition,
health services quality and vaccine concerns,
which underscores the need for a whole system
approach to raise vaccination rates from their currently very low levels. This includes SBC programs
working at multiple societal levels and through
different actors and communication channels,
alongside strengthened health systems for immunization services.

TABLE 2 SPOUSAL OPPOSITION, HEALTH
FACILITY PROBLEMS, AND VACCINE
CONCERNS ARE MAIN BARRIERS TO
VACCINATION
Among women who did not vaccinate her youngest child
(n=1,847), percentage who cited certain reasons for not
vaccinating

4

REASON

%

Spousal opposition

34

Facility distance

14

Fear needles

12

Vaccines no safe/fear side effects

10

Facility closed

9

Too expensive

6

No female provider

4

Poor quality service

4

Don't know where to go

3

Vaccines not effective

2

Disrespectful provider

1

Religious/community leader opposition

1

Spousal and health worker support is critical

•
•

Almost three-quarters of respondents reported that their
spouse influences their decision to vaccinate a child, while
few women mentioned mothers-in-law (8%), mothers
(6%), and health providers (5%).
Spousal and health provider support is critical for promoting vaccination uptake. In regression analyses, women
whose spouses supported their vaccination decision were
1.6 and 1.4 times as likely to have their child receive three
doses of DPT and measles vaccine than those without
spousal support, respectively. Women who said health
providers influenced the decision were 2.6 and 1.6 times
as likely to have their child receive all basic vaccinations
and measles vaccine, respectively. More research is
needed to better understand how health providers have
influenced decisions and ways to support such practices
in order to improve vaccine uptake (Figure 3).

Programmatic implications
9 SBC programs could maximize effectiveness by specifically engaging spouses and health providers in
vaccination promotion activities. Spouses play an
outsized role in influencing vaccine decisions and
their support is critical for uptake. More research
is needed on male vaccination knowledge, beliefs,
and attitudes in order to inform SBC messaging for
this key group.
9 While few women cite health providers as influencing vaccine decisions, women who said health
providers influenced their vaccination decisions
were significantly more likely to get their child
vaccinated than those who did not. Antenatal care
visits may be an important point of contact to
expand their reach, but more research is needed
on how best to engage health workers in vaccine
promotion during antenatal care visits or other
contact points.
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FIGURE 3 SPOUSES AND HEALTH PROVIDERS INFLUENCE VACCINE UPTAKE
Predicted probabilities* of having a fully vaccinated child aged 12–23 months, or receipt of DPT3 or measles vaccination among
this age group by social influence
Yes

No

53%

38%
34%

34%

26%

24%

13%

Health provider
influences
decision
ALL BASIC VACCINATIONS

15%

Spouse
influences
decision
DPT3 VACCINATION

Spouse
influences
decision

Health provider
influences
decision

MEASLES VACCINATION

*Predicted probabilities of vaccine uptake were derived from mixed-effects logistic regression models adjusted for vaccine-related ideations (Table 1) and
socioeconomic characteristics including household wealth, woman’s age, antenatal care attendance at least 4 times, education (woman and spouse), employment
(woman and spouse), child’s age, sex. All ideational metrics presented are significant at the <0.05 level.

Beliefs about vaccine efficacy and antenatal
care attendance also matters

•
•
•

Women who believed that the illnesses vaccines prevent
are severe were 2.6 times as likely to have a child vaccinated against measles or with three doses of DPT vaccine.
Women who believed that most women in her community trust immunization health providers were 3.1 times as
likely to have her child receive three doses of DPT vaccine.
Women who attended antenatal care at least 4 times
(ANC4+) were more than twice as likely to have a fully vaccinated child than non-users (Figure 4, next page).

Programmatic implications
9 SBC programs should consider reinforcing messages about vaccine safety and efficacy against
severe vaccine-preventable diseases.
9 Women's trust of immunization service providers is
an important factor in vaccine uptake and underscores the need to improve perceived and actual
health services quality.
9 Antenatal care visits may be an important moment
to improve community views of health services
quality, address women’s vaccine hesitancy, and
expand the influence of health providers on vaccination decisions.
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FIGURE 4 VACCINE-RELATED IDEATIONS ASSOCIATED WITH VACCINE UPTAKE
Predicted probabilities* of having a fully vaccinated child aged 12–23 months, or receipt of DPT3 or measles vaccination among
this age group by ideational factor
Yes

No
38%

24%

24%

15%
10%

Many illnesses
vaccines prevent
are severe

8%
Most people in my
community trust
immunization
health providers

DPT3 VACCINATION

Many illnesses
vaccines prevent
are severe
MEASLES VACCINATION

*Predicted probabilities of vaccine uptake were derived from mixed-effects logistic regression models adjusted for vaccine-related ideations (Table 1) and
socioeconomic characteristics including household wealth, woman’s age, antenatal care attendance at least 4 times, education (woman and spouse), employment
(woman and spouse), child’s age, and sex. All ideational metrics presented are significant at the <0.05 level.

Conclusions
The results indicate an important role for SBC programming
to achieve substantial improvements in routine childhood
immunization practices in northwestern Nigeria, even in the
absence of other changes. The most important ideations
for SBC programs to target include fostering social support
mechanisms and addressing beliefs about vaccine efficacy.
Reasons for not vaccinating children are complex and
multi-faceted, including spousal opposition, health system issues, and vaccine concerns were the main barriers
to vaccinating children, which underscores the need for a
whole system approach to raise vaccination rates from their
currently very low levels. SBC programs will need to work
at multiple societal levels and through different actors and

6

communication channels, alongside efforts to strengthen
health systems for immunization services.
Social influences, especially spouses and health care providers, are critical for vaccine promotion. Since spouses have a
clear influence on vaccine decisions, SBC programs include
approaches that specifically address spouses/husbands as an
audience. In contrast, few women cited health care providers as influencing their vaccine decisions, but when they
did, health care provider support increased the likelihood of
vaccination. Programs should think about how to extend the
reach of this influential group, such as through antenatal care
visits, which are important opportunities to improve vaccine
knowledge, address vaccine hesitancy and build community
trust in immunization providers.
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Annex 1: Vaccine-related ideational metrics
9
DIMENSION

DOMAIN

LIKERT-SCALE STATEMENT OR QUESTION

Knowledge

At what age should a child go for his/her first routine vaccination?
In your opinion, how effective are childhood vaccines?

Beliefs about vaccine
safety and efficacy

Many of the illnesses that vaccines are severe
Vaccines have chemicals that can be dangerous to a child’s health

Cognitive

Immunization services in my community are free
Beliefs about health
services

Most people in my community trust health workers who provide immunization
services
Health facilities in my community frequently have the vaccine you need and when
you need it

Emotional

Social

Intentions

Self-efficacy

I know where and when to get my child vaccinated

Social influence

Besides yourself, who else may influence your decision to get a child vaccinated?

Norms

Most parents in my community take their children to the facility for routine
immunization

Intentions

If you had another infant today, how likely is it that you would make sure he/she
received all of his/her recommended vaccines?
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